Changes in Ipsilateral Breast Tumor Recurrence: Characteristics, Treatment, and Survival
Indian Journal of Surgical Oncology · 2026-10 · 17 (10) · 2292-2301
DOI: 10.1007/s13193-025-02497-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Surgical Oncology, online erschienen am 25.02.2026. Verfasst von Wei-Wen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast, Guangdong Province, Jiangmen Central Hospital, No. 23, Haibang St Beijie, Jiangmen City, 529030 People's Republic of China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To characterize temporal trends in clinicopathological features, therapeutic approaches, and survival outcomes of patients with ipsilateral breast tumor recurrence (IBTR).
Methods
A population-based retrospective cohort study (2010-2021) was conducted using the Surveillance, Epidemiology, and End Results (SEER) database. Primary endpoints focused on evaluating temporal trends in clinicopathological features and treatment modalities, while secondary endpoints were the assessment of 3-year overall survival (OS) and breast cancer-specific survival (BCSS). Temporal trends were analyzed using Joinpoint Regression (version 4.9.1.0).
Results
The cohort comprised 9,321 patients with IBTR. Most tumors were early stage (T1: 68.6%, 95% CI 67.6-69.6; N0:88.2%, 95%CI 87.5-88.6) with estrogen receptor-positive/HER2-negative (ER + /HER2-) predominance (72.8%, 95%CI:70.6-75.0), showing a significant annual increase (annual percentage change [APC] = 1.25%, P < 0.001). The utilization of repeat breast-conserving surgery significantly increased post-2014 (APC = 5.19, P = 0.04). The utilization rate of radiotherapy was 10.5% (95%CI:9.4-11.6; P = 0.01), while chemotherapy use exhibited estrogen receptor (ER)-status-dependent variations. The 3-year OS and BCSS rates were 87.1% (95%CI:86.0-88.2) and 93.5% (95%CI:92.7-94.1), respectively, with significantly superior outcomes observed in patients aged < 70 years (P < 0.001).
Conclusions
IBTR predominantly manifests as early stage, lymph node-negative, and ER + /HER2- disease. Treatment approaches for IBTR are evolving. However, the differences in survival outcomes observed among elderly patients indicate possible disparities in treatment based on age, which require further exploration. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s13193-025-02497-0.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast, Guangdong Province, Jiangmen Central Hospital, No. 23, Haibang St Beijie, Jiangmen City, 529030 People's Republic of China.
- Department of General Surgery, School of Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, People's Republic of China.
ORCID-Profile: Yong Li
Zitieren
APA
Li, W. W., Zhang, Q. C., Chen, C. M., Xu, B., & Li, Y. (2026). Changes in Ipsilateral Breast Tumor Recurrence: Characteristics, Treatment, and Survival. Indian Journal of Surgical Oncology, 17(10), 2292-2301. https://doi.org/10.1007/s13193-025-02497-0
Vancouver
Li WW, Zhang QC, Chen CM, Xu B, Li Y. Changes in Ipsilateral Breast Tumor Recurrence: Characteristics, Treatment, and Survival. Indian Journal of Surgical Oncology. 2026;17(10):2292-2301. doi:10.1007/s13193-025-02497-0
BibTeX
@article{Li2026,
author = {Li, Wei-Wen and Zhang, Qun-Chen and Chen, Chun-Mei and Xu, Bo and Li, Yong},
title = {Changes in Ipsilateral Breast Tumor Recurrence: Characteristics, Treatment, and Survival},
journal = {Indian Journal of Surgical Oncology},
year = {2026},
volume = {17},
number = {10},
pages = {2292--2301},
doi = {10.1007/s13193-025-02497-0}
}
EUVIMED